Refine Your Search

  • Solutions

  • Therapeutic Areas

  • Resource Type

Extending the Use of Antivirals to Treat Influenza in Infants

Scientists from d3 Medicine—part of Certara’s Strategic Consulting division—helped Roche apply an integrated clinical pharmacology program to support the development and global approval of Tamiflu for infants.

Solution: Biosimulation, Drug Development & Regulatory Strategy, PBPK Modeling & Simulation, PK/PD Modeling & Simulation
Therapeutic Area: Infectious Disease, Pediatrics
More Info

Precision Dosing Takes Shape

One size does not fit all, reports Certara’s CEO, Edmundo Muniz, and in situations when pharmacokinetic data may be difficult or impossible to obtain, modeling and simulation will stand alone.

Author(s): Edmundo Muniz
Solution: Biosimulation, PBPK Modeling & Simulation
Publication: Manufacturing Chemist
More Info

The Game Changer

Modeling and simulation in drug development could change the commercial and regulatory landscape forever… and can deliver significant business, scientific and clinical value to companies.

Author(s): Edmundo Muniz
Solution: Biosimulation, Drug Development & Regulatory Strategy, PBPK Modeling & Simulation, PK/PD Modeling & Simulation
Publication: Pf Magazine
More Info
Learn More
LinkedIn